Sugi Holdings Co.,Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sugi Holdings Co.,Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 92% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Feb 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥176Over the last 3 years, every ¥100 of reported profit came with ¥176 of operating cash.
Higher than 79% of Healthcare companies in Japan.
Self-Funding Ratio
1.9×Over the last 3 years its own operating cash covered its investment spending (capex) 1.9 times.
Higher than 61% of Healthcare companies in Japan.
Cash Locked Ratio
¥1For every ¥100 of sales, ¥1 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥4 tied up three years earlier.
Less money tied up than 80% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 92% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥8Sales grew 51% in 3 years; of every extra ¥100 of sales, ¥8 became extra profit.
Higher than 56% of Healthcare companies in Japan.
Asset Productivity Ratio
+51% / +75%In 3 years sales changed by +51% while total assets changed by +75%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
3.2×Debt due within a year is covered 3.2 times by its yearly operating cash.
Higher than 77% of Healthcare companies in Japan.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Lower than 53% of Healthcare companies in Japan.
Tangible Assets Ratio
92%Of every ¥100 the company owns, ¥92 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 69% of Healthcare companies in Japan.
Tangible Net Worth Ratio
82%Of every ¥100 of net worth, ¥82 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 69% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Sugi Holdings Co.,Ltd. owes ¥0.50 for every ¥1 it owns. Net profit rose 75% in the year to Feb 2026, and grew 33% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Feb 2026.
P/E ratio
16.2Investors pay ¥16.2 for every ¥1 of Sugi Holdings Co.,Ltd.'s yearly profit, higher than 51% of Healthcare companies in Japan.
P/B ratio
1.54The share price is 1.54 times Sugi Holdings Co.,Ltd.'s book value per share, lower than 51% of Healthcare companies in Japan.
Market cap
¥485.9 BThe total market value of all of Sugi Holdings Co.,Ltd.'s shares at today's price (share price × number of shares), larger than 91% of Healthcare companies in Japan. PosiCap size class: Meso Cap.
Net worth (book value)
¥316.2 BWhat Sugi Holdings Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Aug 2026).
Book value per share
¥849.62Net worth divided by the number of shares. The share price of ¥1,306 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
9.9%Sugi Holdings Co.,Ltd. earned 9.9% on its shareholders' money over the last year, higher than 64% of Healthcare companies in Japan.
Owes vs Owns
0.50×Sugi Holdings Co.,Ltd. owes ¥0.50 for every ¥1 it owns (low), higher than 61% of Healthcare companies in Japan.
Dividend yield
1.36%Sugi Holdings Co.,Ltd. pays 1.36% of its share price as dividends a year, lower than 87% of dividend-paying Healthcare companies in Japan.
Revenue growth
+15%Revenue rose 15% in the year to Feb 2026, and grew 15% a year on average over 3 years.
Profit growth
+75%Net profit rose 75% in the year to Feb 2026, and grew 33% a year on average over 3 years.
Profit margin
4.5%Sugi Holdings Co.,Ltd. keeps ¥4 of every ¥100 of revenue as net profit.
Cash quality
1.9×Cash from Sugi Holdings Co.,Ltd.'s business was 1.9× its reported profit in the year to Feb 2026 — its profit turned into cash.
Interest cover
55.1×Sugi Holdings Co.,Ltd.'s operating profit covered its interest costs 55.1 times in the year to Feb 2026.
Cash vs debt
Net cashSugi Holdings Co.,Ltd. held ¥17.2 B more cash than debt (net cash) at Feb 2026.
Questions
What is Sugi Holdings Co.,Ltd.'s P/E ratio?
Investors pay ¥16.2 for every ¥1 of Sugi Holdings Co.,Ltd.'s yearly profit, higher than 51% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sugi Holdings Co.,Ltd.: ¥485.9 B ÷ ¥316.2 B (31 Aug 2026) = 1.5.
What is Sugi Holdings Co.,Ltd.'s return on equity?
Sugi Holdings Co.,Ltd. earned 9.9% on its shareholders' money over the last year, higher than 64% of Healthcare companies in Japan.
How much does Sugi Holdings Co.,Ltd. owe compared with what it owns?
Sugi Holdings Co.,Ltd. owes ¥0.50 for every ¥1 it owns (low), higher than 61% of Healthcare companies in Japan.
Does Sugi Holdings Co.,Ltd. pay a dividend?
Yes. Sugi Holdings Co.,Ltd. pays 1.36% of its share price as dividends a year, lower than 87% of dividend-paying Healthcare companies in Japan.
Is Sugi Holdings Co.,Ltd.'s revenue growing?
Revenue rose 15% in the year to Feb 2026, and grew 15% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.